Ding Y, Liu W. Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons. Acta Derm Venereol [Internet]. 2026 Apr. 16 [cited 2026 Apr. 24];106:adv-2025. Available from: https://medicaljournalssweden.se/actadv/article/view/45950